Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
暂无分享,去创建一个
A. Gennery | H. Greinix | R. Knobler | D. Pulanić | A. Piekarska | A. Flinn | N. Worel | R. Crossland | G. Stary | J. Lacerda | I. Bojanić | Carolina P. Pacini | Kimberly J. Schell
[1] H. Greinix,et al. Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape , 2022, Leukemia.
[2] S. Paczesny,et al. Current Definitions and Clinical Implications of Biomarkers in Graft Versus Host Disease. , 2022, Transplantation and cellular therapy.
[3] B. Bonnotte,et al. Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD , 2022, Frontiers in Immunology.
[4] C. Bock,et al. Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation , 2021, The Journal of experimental medicine.
[5] T. Luft,et al. Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells. , 2021, Cytotherapy.
[6] F. Locatelli,et al. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. , 2021, The New England journal of medicine.
[7] E. Muñoz-Elías,et al. Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center Stage , 2021, Frontiers in Immunology.
[8] C. Solano,et al. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant , 2021, Journal of clinical apheresis.
[9] S. Montoto,et al. Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study , 2021, Haematologica.
[10] H. Vrielink,et al. Analysis of extracorporeal photopheresis within the frame of the WAA register. , 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[11] R. Cairoli,et al. Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial , 2021, Experimental Hematology & Oncology.
[12] E. Mischak-Weissinger,et al. Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease , 2021, Frontiers in Immunology.
[13] J. Chou,et al. Thymopoiesis, Alterations in Dendritic Cells and Tregs, and Reduced T Cell Activation in Successful Extracorporeal Photopheresis Treatment of GVHD , 2021, Journal of Clinical Immunology.
[14] E. L. Potter,et al. Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease , 2021, Science Translational Medicine.
[15] B. Bonnotte,et al. Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect , 2021, Oncoimmunology.
[16] C. Bock,et al. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease , 2020, Science Translational Medicine.
[17] R. Wäsch,et al. Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease , 2020, Bone Marrow Transplantation.
[18] Amanda M Li,et al. “Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation” , 2020, Frontiers in Immunology.
[19] C. Klemke,et al. European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1 , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[20] A. Costa-Pereira,et al. Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker , 2020, Future science OA.
[21] R. V. van Lier,et al. Tissue-resident memory CD8+ T cells shape local and systemic secondary T cell responses , 2020, Nature Immunology.
[22] J. Winters,et al. Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease , 2020, Journal of clinical apheresis.
[23] M. Mihm,et al. Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host-disease. , 2020, The Journal of clinical investigation.
[24] P. Wolf,et al. Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time , 2020, Transfusion Medicine and Hemotherapy.
[25] R. Edelson,et al. Extracorporeal Photochemotherapy: Mechanistic Insights Driving Recent Advances and Future Directions , 2020, The Yale journal of biology and medicine.
[26] Yiping Fan,et al. Developmental plasticity allows outside-in immune responses by resident memory T cells , 2020, Nature Immunology.
[27] J. Snowden,et al. Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD) , 2020, Frontiers in Immunology.
[28] G. Berlin,et al. Extracorporeal photopheresis for graft‐vs‐host disease: A literature review and treatment guidelines proposed by the Nordic ECP Quality Group , 2020, European journal of haematology.
[29] R. Filler,et al. Rapid Production of Physiologic Dendritic Cells (phDC) for Immunotherapy. , 2020, Methods in molecular biology.
[30] H. Hackstein,et al. CD71 surface analysis of T cells: a simple alternative for extracorporeal photopheresis quality control , 2020, Vox sanguinis.
[31] N. García-Barberá,et al. Identification of Circulating microRNA Signatures As Potential Noninvasive Biomarkers for Prediction to Response to Extracorporeal Photoapheresis in Patients with Graft Versus Host Disease , 2019, Blood.
[32] Heidi Chen,et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. , 2019, Blood advances.
[33] J. Ritz,et al. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease. , 2019, Blood advances.
[34] J. Ritz,et al. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease , 2019, Front. Immunol..
[35] B. Golubić Ćepulić,et al. An automated mini buffy coat preparation method for use in mini extracorporeal photopheresis treatment of graft‐vs‐host‐disease in a low body weight pediatric patient , 2019, Journal of clinical apheresis.
[36] E. Elinav,et al. Mutual interplay between IL-17–producing γδT cells and microbiota orchestrates oral mucosal homeostasis , 2019, Proceedings of the National Academy of Sciences.
[37] R. Handgretinger,et al. Monocytes show immunoregulatory capacity on CD4+ T cells in a human in‐vitro model of extracorporeal photopheresis , 2018, Clinical and experimental immunology.
[38] D. K. Jung,et al. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[39] E. Yannaki,et al. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study , 2018, Journal of clinical apheresis.
[40] T. Luft,et al. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects , 2018, Front. Immunol..
[41] J. Raval,et al. Extracorporeal photopheresis and personalized medicine in the 21st century: The future's so bright! , 2018, Journal of clinical apheresis.
[42] E. Weissinger,et al. Biomarkers in chronic graft-versus-host disease: quo vadis? , 2018, Bone Marrow Transplantation.
[43] H. Sengeløv,et al. Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease , 2018, Bone Marrow Transplantation.
[44] B. Blazar,et al. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets. , 2017, The New England journal of medicine.
[45] R. DeSimone,et al. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations , 2017, Journal of clinical apheresis.
[46] H. Greinix,et al. Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease , 2017, Front. Immunol..
[47] S. Sloan,et al. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee , 2017, Journal of clinical apheresis.
[48] J. Riggert,et al. In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cells , 2017, Central-European journal of immunology.
[49] H. Greinix,et al. Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease , 2017, Front. Immunol..
[50] A. Gennery,et al. Treatment of Pediatric Acute Graft-versus-Host Disease—Lessons from Primary Immunodeficiency? , 2017, Front. Immunol..
[51] A. Gennery,et al. The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society , 2017, British journal of haematology.
[52] T. Lener,et al. An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications , 2017, Journal of clinical apheresis.
[53] P. Taylor,et al. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids , 2017, Transplantation.
[54] P. Chiusolo,et al. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo. , 2016, Transplantation.
[55] T. Honda,et al. Novel insights into cutaneous immune systems revealed by in vivo imaging. , 2016, Allergology international : official journal of the Japanese Society of Allergology.
[56] J. Ritz,et al. Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD. , 2016, Blood.
[57] R. Cairoli,et al. Response of steroid‐refractory chronic graft‐versus‐host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles , 2016, Transfusion.
[58] D. Couriel,et al. The effect of extracorporeal photopheresis on T cell response in chronic graft-versus-host disease , 2016, Leukemia & lymphoma.
[59] D. A. Baerenwald,et al. Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T‐cell lymphoma , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[60] A. Im,et al. Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[61] E. Wong,et al. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR‐XTS® instrument is more efficient and better tolerated in children with steroid‐refractory graft‐versus‐host disease , 2015, Pediatric blood & cancer.
[62] B. Bonnotte,et al. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes. , 2015, The Journal of allergy and clinical immunology.
[63] David C. Gondek,et al. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells , 2015, Science.
[64] Anna Maria Ferriero,et al. Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases: Results from a Health Technology Assessment in Italy. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[65] Daniel Wolff,et al. Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report , 2022 .
[66] S. Kaech,et al. Smad4 Promotes Differentiation of Effector and Circulating Memory CD8 T Cells but Is Dispensable for Tissue-Resident Memory CD8 T Cells , 2015, The Journal of Immunology.
[67] Benjamin Djulbegovic,et al. Platelet Transfusion: A Clinical Practice Guideline From the AABB , 2015, Annals of Internal Medicine.
[68] Paul J Martin,et al. How we treat chronic graft-versus-host disease. , 2015, Blood.
[69] F. Fagioli,et al. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from a large single-center study , 2014, Transfusion.
[70] B. Djulbegovic,et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[71] Isobel S Okoye,et al. MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells , 2014, Immunity.
[72] T. Chatila,et al. Regulatory T cells: exosomes deliver tolerance. , 2014, Immunity.
[73] A. Hayday,et al. Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling. , 2014, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[74] M. Murad,et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis , 2014, Blood research.
[75] J. Scarisbrick,et al. Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD , 2014, Bone Marrow Transplantation.
[76] D. Barber,et al. Intravascular staining for discrimination of vascular and tissue leukocytes , 2014, Nature Protocols.
[77] H. Greinix,et al. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease. , 2013, Blood.
[78] Liu Wang-qing,et al. Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards. , 2014, Cytometry. Part B, Clinical cytometry.
[79] R. Punzalan,et al. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft‐versus‐host disease in paediatric patients , 2013, British journal of haematology.
[80] A. Tomaszewska,et al. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. , 2013, Transplantation proceedings.
[81] C. Eby,et al. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis , 2013, Transfusion.
[82] A. Bosi,et al. Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process , 2013, Transfusion.
[83] M. Robin,et al. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[84] H. Sung,et al. Cutting Edge: Intravascular Staining Redefines Lung CD8 T Cell Responses , 2012, The Journal of Immunology.
[85] L. Scudeller,et al. Response and survival of patients with chronic graft‐versus‐host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications , 2012, Transfusion.
[86] G. Mufti,et al. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD , 2012, Bone Marrow Transplantation.
[87] M. Imamura,et al. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)? , 2012, Current stem cell research & therapy.
[88] S. Papageorgiou,et al. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[89] R. Clark,et al. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity , 2012, Nature.
[90] P. Krammer,et al. Molecular Mechanisms of Treg-Mediated T Cell Suppression , 2012, Front. Immun..
[91] P. Taylor,et al. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. , 2011, Blood.
[92] D. Parenti,et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[93] E. Wherry,et al. Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection , 2011, The Journal of Immunology.
[94] B. Kurland,et al. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium , 2011, Haematologica.
[95] Thomas Gebhardt,et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells , 2011, Nature.
[96] R. Balogun,et al. Therapeutic apheresis in critically ill patients , 2011, Journal of clinical apheresis.
[97] M. Mohty,et al. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[98] D. Ward. Extracorporeal photopheresis: How, when, and why , 2011, Journal of clinical apheresis.
[99] Hongyu Zhao,et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. , 2010, Blood.
[100] C. Flowers,et al. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft‐versus‐host disease , 2010, Transfusion.
[101] T. Braun,et al. Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[102] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[103] J. Klassen. The role of photopheresis in the treatment of graft-versus-host disease. , 2010, Current oncology.
[104] T. Moen,et al. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells. , 2009, Clinical immunology.
[105] H. Hackstein,et al. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications , 2009, Transfusion.
[106] Heidi Chen,et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[107] A. Enk,et al. Extracorporeal Photophoresis Augments Function of CD4+CD25+FoxP3+ Regulatory T Cells by Triggering Adenosine Production , 2009, Transplantation.
[108] F. Sallusto,et al. Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity , 2009, European journal of immunology.
[109] M. Kouba,et al. Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. , 2009, Blood.
[110] E. Bisaccia,et al. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T‐cell lymphoma , 2009, The British journal of dermatology.
[111] A. Balduzzi,et al. Regulatory T Cells and Extracorporeal Photochemotherapy: Correlation With Clinical Response and Decreased Frequency of Proinflammatory T Cells , 2009, Transplantation.
[112] Thomas Gebhardt,et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus , 2009, Nature Immunology.
[113] P. Quaglino,et al. Reciprocal Modulation of Circulating CD4+CD25+bright T Cells Induced by Extracorporeal Photochemotherapy in Cutaneous T-Cell Lymphoma and Chronic GRAFT- Versus-Host-Disease Patients , 2009, International journal of immunopathology and pharmacology.
[114] F. Ginhoux,et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation , 2009, The Journal of experimental medicine.
[115] A. Morita,et al. Experimental Extracorporeal Photopheresis Inhibits the Sensitization and Effector Phases of Contact Hypersensitivity via Two Mechanisms: Generation of IL-10 and Induction of Regulatory T Cells1 , 2008, The Journal of Immunology.
[116] L. Bouzas,et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. , 2008, Blood.
[117] E. Gatza,et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. , 2008, Blood.
[118] P. Taylor,et al. Extracorporeal Photopheresis Normalizes Some Lymphocyte Subsets (Including T Regulatory Cells) in Chronic Graft‐Versus‐Host‐Disease , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[119] C. Cilio,et al. Regulatory T cell‐associated activity in photopheresis‐induced immune tolerance in recent onset type 1 diabetes children , 2008, Clinical and experimental immunology.
[120] P. Rubegni,et al. Extracorporeal photopheresis affects co‐stimulatory molecule expression and interleukin‐10 production by dendritic cells in graft‐versus‐host disease patients , 2008, Clinical and experimental immunology.
[121] T. Schwarz. 25 years of UV‐induced Immunosuppression Mediated by T Cells—From Disregarded T Suppressor Cells to Highly Respected Regulatory T Cells † , 2007, Photochemistry and photobiology.
[122] P. Rubegni,et al. CD4+CD25+ Lymphocyte Subsets in Chronic Graft versus Host Disease Patients Undergoing Extracorporeal Photochemotherapy , 2007, International journal of immunopathology and pharmacology.
[123] A. Balduzzi,et al. Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T-Cells in Patients With Graft-Versus-Host Disease , 2007, Transplantation.
[124] F. Emma,et al. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. , 2007, Transplantation.
[125] D. Harris,et al. Correlation of the CD4+CD25high T‐regulatory cells in recipients and their corresponding donors to acute GVHD , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[126] M. Roncarolo,et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. , 2007, International immunology.
[127] T. Huizinga,et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.
[128] F. Meloni,et al. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. , 2007, Transplantation proceedings.
[129] K. Rezvani,et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. , 2006, Blood.
[130] W. Selby,et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.
[131] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[132] E. Shpall,et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. , 2006, Blood.
[133] S. Kim,et al. Regulation of cytokine production during phagocytosis of apoptotic cells , 2006, Cell Research.
[134] R. Spíšek,et al. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft‐versus‐host disease , 2006, Transfusion.
[135] J. Rémy-Martin,et al. Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion , 2006, Cell Death and Differentiation.
[136] H. Greinix,et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. , 2006, Haematologica.
[137] P. Taylor,et al. Lymphocytes treated by extracorporeal photopheresis can down‐regulate cytokine production in untreated monocytes , 2005, Photodermatology, photoimmunology & photomedicine.
[138] J. Ritz,et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. , 2005, Blood.
[139] F. Foss,et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors , 2005, Bone Marrow Transplantation.
[140] Y. Aragane,et al. Intravenous Infusion of Syngeneic Apoptotic Cells by Photopheresis Induces Antigen-Specific Regulatory T Cells 1 , 2005, The Journal of Immunology.
[141] E. Giorda,et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. , 2005, Transplantation.
[142] K. Scharffetter-Kochanek,et al. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases. , 2005, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[143] A. Rudensky,et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.
[144] C. Thoburn,et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. , 2004, Blood.
[145] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[146] Ming-Tseh Lin,et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. , 2003, The New England journal of medicine.
[147] S. Ziegler,et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.
[148] D. Couriel,et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results , 2003, Bone Marrow Transplantation.
[149] T. Alcindor,et al. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis , 2002, Bone Marrow Transplantation.
[150] G. Gorgun,et al. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. , 2002, Blood.
[151] R. Storb,et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.
[152] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[153] R. Washko,et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. , 1999, Journal of the American Academy of Dermatology.
[154] W. Macey,et al. Photopheresis: clinical applications and mechanism of action. , 1999, The journal of investigative dermatology. Symposium proceedings.
[155] L. Laroche,et al. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. , 1994, Transfusion science.
[156] S. Rockman,et al. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. , 1990, The Journal of clinical investigation.
[157] K Wolff,et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.